Changes in adiponectin receptor expression in muscle and adipose tissue of type 2 diabetic patients during rosiglitazone therapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
1999 • 4,825 citations
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
2003 • 3,114 citations
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
2001 • 1,903 citations
PPARγ Ligands Increase Expression and Plasma Concentrations of Adiponectin, an Adipose-Derived Protein
2001 • 1,659 citations
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
2001 • 896 citations
Induction of Adiponectin, a Fat-Derived Antidiabetic and Antiatherogenic Factor, by Nuclear Receptors
2003 • 732 citations
Insulin/Foxo1 Pathway Regulates Expression Levels of Adiponectin Receptors and Adiponectin Sensitivity
2004 • 543 citations
Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone
2000 • 308 citations
Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARα, PPARγ, and LXR
2003 • 262 citations
Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients
2004 • 142 citations
The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes
2004 • 117 citations
Improved insulin sensitivity and adipose tissue dysregulation after short-term treatment with pioglitazone in non-diabetic, insulin-resistant subjects
2004 • 115 citations